Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States.
about
Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials.Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA.Assessment of costs associated with adverse events in patients with cancer.Incidence of immune checkpoint inhibitor-related colitis in solid tumor patients: A systematic review and meta-analysis.Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review
P2860
Economic Burden of Toxicities Associated with Treating Metastatic Melanoma in the United States.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Economic Burden of Toxicities ...... Melanoma in the United States.
@ast
Economic Burden of Toxicities ...... Melanoma in the United States.
@en
type
label
Economic Burden of Toxicities ...... Melanoma in the United States.
@ast
Economic Burden of Toxicities ...... Melanoma in the United States.
@en
prefLabel
Economic Burden of Toxicities ...... Melanoma in the United States.
@ast
Economic Burden of Toxicities ...... Melanoma in the United States.
@en
P2093
P2860
P1476
Economic Burden of Toxicities ...... Melanoma in the United States.
@en
P2093
Beth Barber
Elizabeth Wehler
Julie Munakata
S Pinar Bilir
Zhongyun Zhao
P2860
P304
P577
2016-06-01T00:00:00Z